Source: Medical Buyer

Organovo: Viscient Biosciences Proposes Merger To Unlock 3D Bioprinting Potential In Drug Discovery With Organovo

SAN DIEGO-Viscient Biosciences ("Viscient"), a biotech therapeutics company working at the intersection of 3D tissue technology and transcriptomics technology to discover and develop drugs across a range of therapeutic areas with...Read More

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Organovo's latest SEC filings

Annual Revenue

Based on data from Organovo's latest SEC filings

Employees

Taylor J. Crouch's photo - President & CEO of Organovo

President & CEO

Taylor J. Crouch

CEO Approval Rating

71/100

Organovo develops tissue and disease models for medical research and therapeutic applications.

Organovo is headquartered ...
Read more